Andrew C. Good

3.1k total citations
45 papers, 1.7k citations indexed

About

Andrew C. Good is a scholar working on Molecular Biology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Andrew C. Good has authored 45 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 22 papers in Computational Theory and Mathematics and 11 papers in Organic Chemistry. Recurrent topics in Andrew C. Good's work include Computational Drug Discovery Methods (22 papers), Chemical Synthesis and Analysis (8 papers) and Hepatitis C virus research (6 papers). Andrew C. Good is often cited by papers focused on Computational Drug Discovery Methods (22 papers), Chemical Synthesis and Analysis (8 papers) and Hepatitis C virus research (6 papers). Andrew C. Good collaborates with scholars based in United States, United Kingdom and Australia. Andrew C. Good's co-authors include Irwin D. Kuntz, Daniel A. Gschwend, Tudor I. Oprea, W. Graham Richards, Sung‐Sau So, Ramkumar Rajamani, Mark A. Hermsmeier, Richard A. Lewis, Jonathan Mason and Brian Kelley and has published in prestigious journals such as Blood, Journal of Medicinal Chemistry and Organic Letters.

In The Last Decade

Andrew C. Good

44 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew C. Good United States 22 985 971 426 223 205 45 1.7k
Matthew T. Stahl United States 3 1.2k 1.3× 1.0k 1.1× 405 1.0× 294 1.3× 230 1.1× 7 2.0k
Thomas Mietzner Germany 10 1.2k 1.2× 1.2k 1.3× 658 1.5× 183 0.8× 196 1.0× 11 2.1k
Simon F. Semus United States 11 1.3k 1.3× 1.1k 1.1× 367 0.9× 257 1.2× 264 1.3× 17 1.9k
Giovanna Tedesco Italy 12 1.1k 1.1× 891 0.9× 386 0.9× 218 1.0× 171 0.8× 15 1.6k
William R. Pitt United Kingdom 24 1.3k 1.3× 691 0.7× 625 1.5× 311 1.4× 179 0.9× 53 2.4k
Oliver Korb United Kingdom 17 1.4k 1.4× 922 0.9× 461 1.1× 285 1.3× 235 1.1× 34 2.1k
Stefan Senger United Kingdom 15 1.1k 1.1× 969 1.0× 373 0.9× 307 1.4× 175 0.9× 28 1.9k
Todd Ewing United States 11 1.3k 1.4× 1.1k 1.1× 343 0.8× 236 1.1× 139 0.7× 14 1.8k
Jean‐François Truchon Canada 12 862 0.9× 756 0.8× 323 0.8× 212 1.0× 178 0.9× 19 1.4k
Pieter F. W. Stouten United States 20 1.4k 1.4× 696 0.7× 313 0.7× 306 1.4× 121 0.6× 54 2.1k

Countries citing papers authored by Andrew C. Good

Since Specialization
Citations

This map shows the geographic impact of Andrew C. Good's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew C. Good with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew C. Good more than expected).

Fields of papers citing papers by Andrew C. Good

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew C. Good. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew C. Good. The network helps show where Andrew C. Good may publish in the future.

Co-authorship network of co-authors of Andrew C. Good

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew C. Good. A scholar is included among the top collaborators of Andrew C. Good based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew C. Good. Andrew C. Good is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Agafonov, Roman V., Prasoon Chaturvedi, Scott J. Eron, et al.. (2022). CFT7455, a Novel IKZF1/3 Degrader, Demonstrates Potent Anti-Tumor Activity in Models of Non-Hodgkin's Lymphoma As a Single Agent or in Combination with Clinically Approved Agents. Blood. 140(Supplement 1). 11575–11575. 1 indexed citations
2.
Chen, Jie, Qian Zhao, Li‐Qiang Sun, et al.. (2016). Structure-activity relationships of 4-hydroxy-4-biaryl-proline acylsulfonamide tripeptides: A series of potent NS3 protease inhibitors for the treatment of hepatitis C virus. Bioorganic & Medicinal Chemistry Letters. 27(3). 590–596. 5 indexed citations
3.
Wu, Yong‐Jin, Yunhui Zhang, Weixu Zhai, et al.. (2015). Macrocyclic prolinyl acyl guanidines as inhibitors of β-secretase (BACE). Bioorganic & Medicinal Chemistry Letters. 25(22). 5040–5047. 13 indexed citations
4.
Good, Andrew C., Jinyu Liu, Bradford Hirth, et al.. (2012). Implications of Promiscuous Pim-1 Kinase Fragment Inhibitor Hydrophobic Interactions for Fragment-Based Drug Design. Journal of Medicinal Chemistry. 55(6). 2641–2648. 36 indexed citations
5.
Lopez, Omar D., Van N. Nguyen, Denis R. St. Laurent, et al.. (2012). HCV NS5A replication complex inhibitors. Part 3 : discovery of potent analogs with distinct core topologies. Bioorganic & Medicinal Chemistry Letters. 23(3). 779–784. 23 indexed citations
6.
Toyn, Jeremy H., Jere E. Meredith, Donna M. Barten, et al.. (2011). Monosubstituted γ-lactam and conformationally constrained 1,3-diaminopropan-2-ol transition-state isostere inhibitors of β-secretase (BACE). Bioorganic & Medicinal Chemistry Letters. 21(22). 6916–6924. 16 indexed citations
7.
Nicholls, Anthony, Georgia B. McGaughey, Robert P. Sheridan, et al.. (2010). Molecular Shape and Medicinal Chemistry: A Perspective. Journal of Medicinal Chemistry. 53(10). 3862–3886. 254 indexed citations
8.
Wu, Yong‐Jin, Yunhui Zhang, Andrew C. Good, et al.. (2009). Synthesis and SAR of hydroxyethylamine based phenylcarboxyamides as inhibitors of BACE. Bioorganic & Medicinal Chemistry Letters. 19(10). 2654–2660. 11 indexed citations
9.
Good, Andrew C.. (2007). Novel DOCK clique driven 3D similarity database search tools for molecule shape matching and beyond: Adding flexibility to the search for ligand kin. Journal of Molecular Graphics and Modelling. 26(3). 656–666. 7 indexed citations
10.
Good, Andrew C., Mark A. Hermsmeier, & Sally Hindle. (2004). Measuring CAMD technique performance: A virtual screening case study in the design of validation experiments. Journal of Computer-Aided Molecular Design. 18(7-9). 529–536. 51 indexed citations
11.
Schnur, Dora M., Brett R. Beno, Andrew C. Good, & Andrew J. Tebben. (2004). Approaches to Target Class Combinatorial Library Design. Methods in molecular biology. 275. 355–377. 11 indexed citations
12.
Hubbard, Roderick E., et al.. (2003). Analysis and optimization of structure-based virtual screening protocols. Journal of Molecular Graphics and Modelling. 22(1). 41–53. 18 indexed citations
13.
Good, Andrew C. & Daniel L. Cheney. (2003). Analysis and optimization of structure-based virtual screening protocols (1): exploration of ligand conformational sampling techniques. Journal of Molecular Graphics and Modelling. 22(1). 23–30. 15 indexed citations
14.
Slater, Martin J., David Andrews, Berwyn Clarke, et al.. (2002). Design and synthesis of ethyl pyrrolidine-5,5-trans-lactams as inhibitors of hepatitis C virus NS3/4A protease. Bioorganic & Medicinal Chemistry Letters. 12(23). 3359–3362. 13 indexed citations
15.
Good, Andrew C., Stanley R. Krystek, & Jonathan Mason. (2000). High-throughput and virtual screening: core lead discovery technologies move towards integration. Drug Discovery Today. 5(12). 61–69. 33 indexed citations
16.
Gschwend, Daniel A., Andrew C. Good, & Irwin D. Kuntz. (1996). Molecular docking towards drug discovery. Journal of Molecular Recognition. 9(2). 175–186. 207 indexed citations
17.
Good, Andrew C. & Irwin D. Kuntz. (1995). Investigating the extension of pairwise distance pharmacophore measures to triplet-based descriptors. Journal of Computer-Aided Molecular Design. 9(4). 373–379. 22 indexed citations
18.
Good, Andrew C., Todd Ewing, Daniel A. Gschwend, & Irwin D. Kuntz. (1995). New molecular shape descriptors: Application in database screening. Journal of Computer-Aided Molecular Design. 9(1). 1–12. 34 indexed citations
19.
Good, Andrew C., Stephen J. Peterson, & W. Graham Richards. (1993). QSAR's from similarity matrices. Technique validation and application in the comparison of different similarity evaluation methods. Journal of Medicinal Chemistry. 36(20). 2929–2937. 55 indexed citations
20.
Good, Andrew C., Sung‐Sau So, & W. Graham Richards. (1993). Structure-activity relationships from molecular similarity matrices. Journal of Medicinal Chemistry. 36(4). 433–438. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026